Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (171-180 of 243) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Baseline cognition and demographic, lifestyle, and cardiovascular risk factors in US POINTERKathryn V Papp, Sarah Tomaszewski Farias, Marjorie Howard, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|March 12, 2026
Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individualsCharles C Windon, Elena Tsoy, Jennifer Livaudais-Toman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2025
Tau biology, biomarkers, and therapeuticsBess Frost, Hartmuth Kolb, Alicia Algeciras-Schimnich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Biomarkers in Medicine|August 25, 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, et al.
Pageof 25

Showing results (171-180 of 243) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Baseline cognition and demographic, lifestyle, and cardiovascular risk factors in US POINTERKathryn V Papp, Sarah Tomaszewski Farias, Marjorie Howard, et al.
Alzheimer'S & Dementia. Behavior & Socioeconomics of Aging|March 12, 2026
Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individualsCharles C Windon, Elena Tsoy, Jennifer Livaudais-Toman, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2025
Tau biology, biomarkers, and therapeuticsBess Frost, Hartmuth Kolb, Alicia Algeciras-Schimnich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Biomarkers in Medicine|August 25, 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, et al.
Pageof 25